Region:Middle East
Author(s):Dev
Product Code:KRAC1991
Pages:83
Published On:October 2025

By Type:The market is segmented into various types of veterinary anti-infectives, including antibiotics, antivirals, antifungals, antiparasitics, vaccines, and others. Among these, antibiotics are the most widely used due to their effectiveness in treating bacterial infections in both livestock and companion animals. The increasing incidence of antibiotic-resistant infections is also driving innovation in this segment, leading to the development of new formulations and delivery methods.

By Application:The application segment includes livestock (cattle, poultry, sheep & goats, pigs), companion animals (dogs, cats, others), aquaculture, and others. The livestock segment holds the largest share due to the high demand for meat and dairy products in the region. The increasing focus on biosecurity measures and disease prevention in livestock farming is also contributing to the growth of this segment.

The Middle East Veterinary Anti Infectives Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health (Merck & Co., Inc.), Elanco Animal Health, Boehringer Ingelheim, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals, Phibro Animal Health, Huvepharma, Norbrook, Calier, Bimeda, ECO Animal Health contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Middle East veterinary anti-infectives market appears promising, driven by increasing investments in animal health and a shift towards preventive care. As livestock producers prioritize animal welfare and productivity, the demand for innovative anti-infective solutions is expected to rise. Additionally, the integration of technology in veterinary practices will enhance disease management and treatment efficacy, further supporting market growth in the coming years.
| Segment | Sub-Segments |
|---|---|
| By Type | Antibiotics Antivirals Antifungals Antiparasitics Vaccines Others |
| By Application | Livestock (Cattle, Poultry, Sheep & Goats, Pigs) Companion Animals (Dogs, Cats, Others) Aquaculture Others |
| By Route of Administration | Oral Injectable Topical Others |
| By Distribution Channel | Veterinary Clinics Pharmacies E-commerce Others |
| By End-User | Farmers Pet Owners Aquaculture Operators Others |
| By Region | GCC Countries (Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman) Levant Region (Jordan, Lebanon, Syria, Palestine) North Africa (Egypt, Morocco, Algeria, Tunisia, Libya) Others |
| By Price Range | Low Medium High Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Veterinary Clinics | 100 | Veterinarians, Clinic Managers |
| Livestock Farms | 90 | Farm Owners, Animal Health Managers |
| Veterinary Distributors | 60 | Sales Managers, Product Managers |
| Regulatory Bodies | 50 | Regulatory Affairs Specialists, Policy Makers |
| Research Institutions | 40 | Research Scientists, Veterinary Epidemiologists |
The Middle East Veterinary Anti Infectives Market is valued at approximately USD 420 million, driven by factors such as the rising prevalence of zoonotic diseases, increasing demand for animal protein, and advancements in veterinary healthcare technologies.